3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
29
Neoplasms
10
Brain Neoplasms
6
Neoplasm Metastasis
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Skin Neoplasms
2
Multiple Myeloma
2
Hematologic Neoplasms
2
Glioma
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Carcinoma, Anaplastic
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligodendroglioma
1
Nonseminomatous germ cell tumor
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Lymphoma
1
Leukemia, Hairy Cell
1
Histiocytosis, Langerhans-Cell
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Ganglioneuroma
1
Ganglioglioma
1
Fever
1
Differentiated Thyroid Cancer (DTC)
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Astrocytoma
1
Interventions
AZD 6244
3
mirdametinib
2
Sirolimus
2
Inhalation
2
Everolimus
2
Acetylcysteine
2
trametinib
1
tipifarnib
1
pirfenidone
1
peginterferon alfa-2b
1
omipalisib
1
cediranib
1
binimetinib
1
Vincristine
1
Vinblastine
1
Temozolomide
1
Surveys and Questionnaires
1
Sunitinib
1
Radiotherapy
1
N-monoacetylcystine
1
Methotrexate
1
Magnetic Resonance Imaging
1
Lovastatin
1
Lenalidomide
1
Ifosfamide
1
Gadolinium DTPA
1
Fluorodeoxyglucose F18
1
Filgrastim
1
Etoposide
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neurofibromatosis 1
×
dabrafenib
×
Clear all
No trials found.